Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Employment agrmnt
Director departure
Inv. presentation
Quarterly results
Appointed director
CC transcript
OSI PHARMACEUTICALS INC (OSIP) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/24/2010 8-K/A Form 8-K - Current report [amend]
07/24/2009 8-K/A Form 8-K - Current report [amend]
12/19/2006 8-K/A Cost Associated with Exit or Disposal Activities
12/15/2005 8-K/A Other Events
12/09/2005 8-K/A Financial Statements and Exhibits
Docs: "Consent of Independent Registered Public Accounting Firm — Ernst & Young LLP to Eyetech Pharmaceuticals, Inc",
"Consolidated Financial Statements of Eyetech Pharmaceuticals, Inc",
"Unaudited Consolidated Financial Statements of Eyetech Pharmaceuticals, Inc",
"Unaudited Pro Forma Condensed Combined Financial Statements"
11/24/2004 8-K/A Other Events, Financial Statements and Exhibits
05/06/2003 8-K/A Financial statements and exhibits
Docs: "THAT WAS PREVIOUSLY REDACTED"
03/17/2003 8-K/A Financial statements and exhibits
Docs: "OSI PHARMACEUTICALS, INC. and ARES TRADING S.A."
03/06/2002 8-K/A Financial statements and exhibits
Docs: "THE CURRENT REPORT ON FORM 8-K FILED BY OSI PHARMACEUTICALS, INC. ON JANUARY 7, 2002 IS HEREBY AMENDED TO INCLUDE THE FINANCIAL INFORMATION REQUIRED IN ITEM 7.",
"CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS"
05/23/2000 8-K/A Acquisition or disposition of assets, Financial statements and exhibits
05/10/1996 8-K/A Financial statements and exhibits

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy